International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers

Laurence Amar(Unit of Functional and Adaptive Biology), Charlotte Lussey‐Lepoutre(Inserm), Giorgio Treglia(Ente Ospedaliero Cantonale), Jacques W.M. Lenders(Radboud University Nijmegen), David Taïeb(Aix-Marseille Université), Martin Faßnacht(University of Würzburg), Dylan Lewis(King's College Hospital NHS Foundation Trust), Massimo Mannelli(University of Florence), Camilo Jiménez(The University of Texas MD Anderson Cancer Center), David R. Taylor(King's College Hospital NHS Foundation Trust), Simon Aylwin(King's College Hospital NHS Foundation Trust), Ashley Grossman(Queen Mary University of London), Andrzej Januszewicz(Hypertension Institute), Henri Timmers(Radboud University Nijmegen), William F. Young(Mayo Clinic in Arizona), Scott Akker, Nicola Tufton(St Bartholomew's Hospital), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Rodney J. Hicks(Flinders Medical Centre), Roderick Clifton‐Bligh(The University of Sydney), Éric Baudin(Institut Gustave Roussy), Karel Pacák(Endocrine Society), Nelly Burnichon(Inserm), Alexandre Buffet(Inserm), Patricia L. M. Dahia(The University of Texas at San Antonio Health Science Center), Mitsuhide Naruse(Ijinkai Takeda General Hospital), Henricus P. M. Kunst(Radboud University Nijmegen), Olivier Steichen(Inserm), Philippe Herman(Université Paris Cité), Anne‐Paule Gimenez‐Roqueplo(Délégation Paris 5)
Nature Reviews Endocrinology
May 21, 2021
Cited by 167


Related Papers